Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.
According to an abstract presented at the American Society for Radiation Oncology (ASTRO) 56th Annual Meeting in September, certain types of metastatic (stage IV) non-small cell lung cancers (NSCLC) can ... Read more
Announced at the European Society for Medical Oncology (ESMO) Meeting 2014, GlaxoSmithKline’s investigational cancer immunotherapeutic, recMAGE-A3, does not increase survival of non-small cell lung cancer (NSCLC) patients when compared to a ... Read more
When an international group of researchers investigated a possible link between lung cancer risk and concomitant respiratory conditions, they found a significantly increased occurrence of lung cancer in patients with ... Read more
New, emerging research continually reminds scientists that although large gains have been made in understanding and treating lung cancer, there is still much to discover and exploit for new treatment ... Read more